Dr Eliza Hawkes is the Clinical Lead for Lymphoma at the Olivia Newton-John Cancer Centre, Austin Health and Eastern Health in Melbourne. After completing her Medical Oncology training in Melbourne, she undertook a research fellowship at the Royal Marsden Hospital in London, UK then a DMedSc in aggressive lymphomas at University of Melbourne. She is an NHMRC research fellow with a research focus on immunotherapy and principal investigator on over 20 local and international clinical lymphoma trials, including 6 of her own Investigator-Initiated Trials.
Eliza Chairs the ALLG High-Grade Lymphoma Disease group and the Australasian Lymphoma Alliance and is a member of the ALLG Scientific Advisory Committee, the Lymphoma and Related Diseases Registry Trial Steering Committee, and EviQ Lymphoma advisory committee.
Deriving value from real-world data sets, initiatives and results from the Australasian Lymphoma Alliance
Despite improved knowledge of molecular heterogeneity in cancer, and recognised bias in clinical trial populations, the majority of cancers are still treated with one-size fits most approaches derived from clinical trial data. Dr Hawkes will discuss the importance of Real-world data sets as a tool to inform clinical practice and future research as well as strategies and successes from a formal approach to real-world research adopted by the Australasian Lymphoma Alliance.